There is a mismatch between the medicare benefit package and the preferences of patients with cancer and their caregivers.

Journal Article (Journal Article)

PURPOSE: To identify insured services that are most important to Medicare beneficiaries with cancer and their family caregivers when coverage is limited. METHODS: A total of 440 participants (patients, n = 246; caregivers, n = 194) were enrolled onto the CHAT (Choosing Health Plans All Together) study from August 2010 to March 2013. The exercise elicited preferences about what benefits Medicare should cover for patients with cancer in their last 6 months of life. Facilitated sessions lasted 2.5 hours, included 8 to 10 participants, and focused on choices about Medicare health benefits within the context of a resource-constrained environment. RESULTS: Six of 15 benefit categories were selected by > 80% of participants: cancer care, prescription drugs, primary care, home care, palliative care, and nursing home coverage. Only 12% of participants chose the maximum level of cancer benefits, a level of care commonly financed in the Medicare program. Between 40% and 50% of participants chose benefits not currently covered by Medicare: unrestricted cash, concurrent palliative care, and home-based long-term care. Nearly one in five participants picked some level of each of these three benefit categories and allocated on average 30% of their resources toward them. CONCLUSION: The mismatch between covered benefits and participant preferences shows that addressing quality of life and the financial burden of care is a priority for a substantial subset of patients with cancer in the Medicare program. Patient and caregiver preferences can be elicited, and the choices they express could suggest potential for Medicare benefit package reform and flexibility.

Full Text

Duke Authors

Cited Authors

  • Taylor, DH; Danis, M; Zafar, SY; Howie, LJ; Samsa, GP; Wolf, SP; Abernethy, AP

Published Date

  • October 1, 2014

Published In

Volume / Issue

  • 32 / 28

Start / End Page

  • 3163 - 3168

PubMed ID

  • 25154830

Pubmed Central ID

  • PMC4263816

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.54.2605


  • eng

Conference Location

  • United States